Country: United States
Language: English
Source: NLM (National Library of Medicine)
Sodium Fluoride (UNII: 8ZYQ1474W7) (Fluoride ion - UNII:Q80VPU408O), Hydrofluoric Acid (UNII: RGL5YE86CZ) (Fluoride ion - UNII:Q80VPU408O)
Laclede, Inc.
DENTAL
PRESCRIPTION DRUG
Topical Fluoride Foam Acidulated Phosphate Fluoride Solution Containing 1.23% w/w Fluoride ion FOR PROFESSIONAL USE ONLY Description : Topical Fluoride Foam is a flavored aqueous foaming solution of acidulated phosphate sodium fluoride with pH of 3.5 and a fluoride ion concentration of 1.23% w/w.
unapproved drug other
TOPICAL FLUORIDE FOAM BUMBLE BEE BUBBLE GUM - ACIDULATED PHOSPHATE FLUORIDE AEROSOL LACLEDE, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- PACKAGE.LABEL PRINCIPAL DISPLAY PANEL TOPICAL FLUORIDE FOAM Acidulated Phosphate Fluoride Solution Containing 1.23% w/w Fluoride ion FOR PROFESSIONAL USE ONLY DESCRIPTION: Topical Fluoride Foam is a flavored aqueous foaming solution of acidulated phosphate sodium fluoride with pH of 3.5 and a fluoride ion concentration of 1.23% w/w. ACTIVE INGREDIENTS: Sodium Fluoride and Hydrofluoric Acid (equivalent to 1.23% w/w Fluoride ion). INACTIVE INGREDIENTS: Purified Water, poloxamer 407, isobutane, poloxamer 234, phosphoric acid, sodium saccharin, flavor. Fluoride Foam TOPICAL FLUORIDE FOAM BUMBLE BEE BUBBLE GUM acidulated phosphate fluoride aerosol PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:548 9 7-50 7 ROUTE OF ADMINISTRATION DENTAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH SO DIUM FLUO RIDE (UNII: 8 ZYQ1474W7) (Fluo ride io n - UNII:Q8 0 VPU40 8 O) Fluo ride io n 10 mg in 1 g HYDRO FLUO RIC ACID (UNII: RGL5YE8 6 CZ) (Fluo ride io n - UNII:Q8 0 VPU40 8 O) Fluo ride io n 2.3 mg in 1 g PRODUCT CHARACTERISTICS COLOR S CORE S HAP E S IZ E FLAVOR BUBBLE GUM (Bubble Gum Flavo r) IMPRINT CODE CONTAINS Laclede, Inc. PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:548 9 7-50 7-17 16 5 g in 1 BOTTLE MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 0 5/0 4/20 0 0 LABELER - Laclede, Inc. (098835994) Revised: 3/2011 Read the complete document